NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 3rd. Investors of record on Friday, January 25th will be paid a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 annualized dividend and a yield of 2.88%. The ex-dividend date is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Wednesday, August, 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.61 by $0.08. The pharmacy operator earned $46.71 billion during the quarter, compared to analysts' expectations of $46.34 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The company's revenue for the quarter was up 2.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.33 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 20th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

15 Wall Street analysts have issued twelve-month target prices for CVS Health's shares. Their forecasts range from $75.00 to $104.00. On average, they expect CVS Health's stock price to reach $91.7857 in the next twelve months. This suggests a possible upside of 32.0% from the stock's current price. View Analyst Price Targets for CVS Health.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media coverage about CVS stock has been trending somewhat positive recently, InfoTrie reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave media stories about the pharmacy operator a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.

CVS Health saw a increase in short interest in January. As of January 31st, there was short interest totalling 14,420,741 shares, an increase of 35.1% from the January 15th total of 10,671,652 shares. Based on an average daily volume of 9,924,659 shares, the short-interest ratio is presently 1.5 days. Approximately 1.1% of the company's stock are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.12%), Oregon Public Employees Retirement Fund (2.46%), Northern Trust Corp (1.76%), Geode Capital Management LLC (1.62%), Bank of New York Mellon Corp (1.43%) and Parnassus Investments CA (1.35%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., First American Bank, Parnassus Investments CA, CI Investments Inc., Harris Associates L P, Kiltearn Partners LLP, DNB Asset Management AS and State Treasurer State of Michigan. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Geode Capital Management LLC, Epoch Investment Partners Inc., Northern Trust Corp, Dimensional Fund Advisors LP, Diamond Hill Capital Management Inc. and Bank of New York Mellon Corp. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $69.53.

CVS Health has a market capitalization of $70.84 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 160,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]